ישראל - עברית - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - טבליות מצופות פילם - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.03 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations

ישראל - עברית - Ministry of Health

abic ltd. - omeprazole - קפסולות - omeprazole 20 mg - omeprazole

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 150 mg - lacosamide

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 200 mg - lacosamide

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 50 mg - lacosamide

ישראל - עברית - Ministry of Health

astellas pharma international b.v., israel - gilteritinib as fumarate - טבליות מצופות פילם - gilteritinib as fumarate 40 mg - gilteritinib

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 100 mg - lacosamide

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - duloxetine as hydrochloride - duloxetine as hydrochloride 30 mg - duloxetine

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - duloxetine as hydrochloride - duloxetine as hydrochloride 60 mg - duloxetine

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 15 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi